RNAZ · Transcode Therapeutics, Inc.
$2.16
-0.03 (-1.15%)
At close · Aug 31
Going-concern doubt
— flagged Aug 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Due to the Company's recurring and expected continuing losses from operations, the Company has concluded there is substantial doubt concerning its ability to continue as a going concern for one year after the issuance of these consolidated financial statements without additional capital becoming available.”View the 10-Q filed Aug 14, 2026
Market Cap
$36.91M
Shares
16.93M
Press releases and events scraped from the company's investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.
Upcoming events
| Date | Event | Type |
|---|---|---|
| 2026-09-23 00:00 UTC | RNA leaders | Event |
Past events
| Date | Event | Type |
|---|---|---|
| 2026-06-18 | TransCode's First Live Virtual R&D Webcast | Webcast |